Molnupiravir: evidence by press release. | Drug Ther Bull;60(1): 2, 2022 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Molnupiravir: evidence by press release.

Cave, James A; Phizackerley, David.

Cave JA; The Downland Practice, Berkshire, UK jcave@bmj.com.
Phizackerley D; DTB, BMJ Journals, London, UK.

Drug Ther Bull ; 60(1): 2, 2022 Jan.

Article in English | MEDLINE | ID: covidwho-2157411

Subject(s)

Cytidine; Hydroxylamines; Cytidine/analogs & derivatives; Humans

Keywords

access; and evaluation; drug-related side effects and adverse reactions; healthcare quality

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytidine / Hydroxylamines Limits: Humans Language: English Journal: Drug Ther Bull Year: 2022 Document Type: Article Affiliation country: Dtb.2021.000064

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytidine / Hydroxylamines Limits: Humans Language: English Journal: Drug Ther Bull Year: 2022 Document Type: Article Affiliation country: Dtb.2021.000064